SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?


To: Short A. Few who wrote (398)10/29/1998 2:45:00 PM
From: Beltropolis Boy  Respond to of 828
 
Safeskin Shares Fall on Concerns About Sales Growth (Update 1)
Bloomberg News
October 29, 1998, 10:07 a.m. PT

(Adds more comment, yesterday's earnings, updates shares.)

.
.
.

Other analysts said they don't foresee problems for the
company, which Forbes magazine recently ranked 15th on its list
of the 200 best small companies.

Still 'Attractive'

"It's an attractive stock and it remains attractive," said
John Arege, an analyst at S&P Equity Group. The company is still
forecasting 25 percent earnings and revenue growth, he said.

"It's a consistent revenue generator" that "continues to
hit its numbers every quarter," Arege said. "We don't see any
reason to downgrade the stock."

Arege has an "accumulate" on the stock, which he said is
equivalent to other analysts' "buy."

news.com